Zoledronate (disodium)

CAT:

804-HY-13777C

Size:

Inquire

Price:

Ask

For price, please contact [email protected]

CAS Number: 131654-46-1
UNSPSC Description: Zoledronate (CGP 42446) disodium is a potent bisphosphonate that effectively inhibits osteoclastogenesis, reducing bone turnover and stabilizing the bone matrix. Zoledronate disodium has demonstrated notable effectiveness in managing Paget's disease of bone by suppressing metabolic activity and alleviating bone pain. Zoledronate disodium is being investigated in the ongoing ZiPP trial for its potential to prevent disease progression in patients with Paget's disease. Zoledronate disodium also exhibits diverse anti-tumor effects in osteosarcoma, further highlighting its multifunctional therapeutic applications.
Target Antigen: Others
Type: Reference compound
Related Pathways: Others
Field of Research: Cancer
Assay Protocol: https://www.medchemexpress.com/zoledronate-disodium.html
Smiles: O=P(O)(C(CN1C=NC=C1)(P(O[Na])(O[Na])=O)O)O
Molecular Weight: 316.05
References & Citations: [1]Bisphosphonates in the management of Paget's disease
Shipping Conditions: Room temperature
Clinical Information: No Development Reported

Cat	Name
MBS5813524	Zoledronate disodium
574949	Zoledronate disodium hydrate
MBS6017819-03	Zoledronic Acid, Disodium Salt, Tetrahydrate (Zoledronate Disodium, CGP-42446A)
MBS6017819-01	Zoledronic Acid, Disodium Salt, Tetrahydrate (Zoledronate Disodium, CGP-42446A)
MBS6017819-02	Zoledronic Acid, Disodium Salt, Tetrahydrate (Zoledronate Disodium, CGP-42446A)
MBS5799832	DOTA Zoledronate
T39333-10mg	DOTA Zoledronate
T39333-5mg	DOTA Zoledronate
T39333-1mg	DOTA Zoledronate
T39333-1g	DOTA Zoledronate